Teleflex Inc (TFX): Thomas Anthony Kennedy , Senior VP, Global Operations of Teleflex Inc sold 15,102 shares on May 16, 2016. The Insider selling transaction was reported by the company on May 18, 2016 to the Securities and Exchange Commission. The shares were sold at $160.20 per share for a total value of $2,419,340.50 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Aug 21, 2015, Patricia C Barron (director) sold 1,500 shares at $132.74 per share price.On May 29, 2015, William Roland Cook (director) sold 8,000 shares at $128.89 per share price.Also, On Mar 9, 2015, Stuart A Randle (director) sold 870 shares at $121.78 per share price.
Teleflex Incorporated: On Thursday, May 19, 2016 heightened volatility was witnessed in Teleflex Incorporated which led to swings in the share price. The shares opened for trading at $157.01 and hit $158.93 on the upside , eventually ending the session at $158.08, with a gain of 0.16% or 0.26 points. The heightened volatility saw the trading volume jump to 1,48,842 shares. The 52-week high of the share price is $163.33 and the company has a market cap of $6,891,656 M . The 52-week low of the share price is at $122.13.
Company has been under the radar of several Street Analysts.Teleflex Incorporated is Reiterated by Barclays to Overweight and the brokerage firm has raised the Price Target to $ 170 from a previous price target of $155 .The Rating was issued on Apr 29, 2016.
Teleflex Incorporated is a provider of medical technology products. The Company designs develops manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company also markets and sells its products to hospitals and healthcare providers. The Company operates its business in six segments: Vascular North America; Anesthesia/Respiratory North America; Surgical North America; Europe the Middle East and Africa (EMEA); Asia and Original Equipment Manufacturer (OEM). The Company manufactures its products at 26 manufacturing sites with manufacturing operations located in the Czech Republic Germany Malaysia Mexico and the United States. The Companys specialty product line consists of a range of catheters including Foley intermittent external and suprapubic; urine collectors; catheterization accessories and products for operative endourology.